COVID-19 & CancerFree The Cancer Letter invites oncology leaders to share insight, strategize on COVID-19 August 06, 2020Vol.46 No.32
COVID-19 & CancerFree Gauging the effects of COVID-19 on cancer mortality August 06, 2020Vol.46 No.32
Free Robert Winn, Otis Brawley: “I could have been George Floyd” August 06, 2020Vol.46 No.32By Robert A. Winn and Otis W. Brawley
FreeGuest Editorial Living as an ethnic minority in a nation laden with discrimination August 06, 2020Vol.46 No.32By Coral Olazagasti and Diana Martins-Welch
Conversation with The Cancer LetterCOVID-19 & CancerFree Walter Lawrence, 95, reflects on the National Cancer Act, medicine, social justice, COVID-19, and Richmond’s vanishing monuments August 06, 2020Vol.46 No.32By Paul Goldberg
Drugs & TargetsFree Tecentriq approved by FDA for BRAF V600 unresectable or metastatic melanoma July 31, 2020Vol.46 No.31
Drugs & TargetsFree FDA approves first cell-based gene therapy for adult patients with relapsed or refractory MCL July 31, 2020Vol.46 No.31
Drugs & TargetsFree Keytruda receives two sBLA acceptances from FDA in TNBC in indications July 31, 2020Vol.46 No.31
